Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs28934571
rs28934571
0.010 GeneticVariation BEFREE Gallbladder cancer does not appear associate with the R249S mutation in TP53. 28428144

2017

dbSNP: rs4986791
rs4986791
0.030 GeneticVariation BEFREE Thr399Ile also may be connected with gallbladder cancer, and both of these polymorphisms apparently have no impact on risk of prostate cancer. 21081146

2011

dbSNP: rs2228000
rs2228000
XPC
0.010 GeneticVariation BEFREE Allelic association analysis for the two single-nucleotide polymorphisms (SNPs) showed that the risk allele T of Ala499Val was significantly associated with GBC [odds ratio (OR)=1.40, 95% confidence interval (CI): 1.11-1.76, P=0.005), with a population attributive risk of 5.3%. 21113018

2011

dbSNP: rs6259
rs6259
0.010 GeneticVariation BEFREE Among women taking oral contraceptives, the effect of SHBG Ex8 + 6 (rs6259) on gallbladder cancer (OR = 6.7, 95% CI = 2.2-20.5; P interaction = 0.001) and stones (OR = 2.3, 95% CI = 1.1-4.9; P-interaction = 0.05) was statistically significant. 19168589

2009

dbSNP: rs4791171
rs4791171
0.010 GeneticVariation BEFREE APC rs11954856, GLI-1 rs2228226, and AXIN-2 rs4791171 were found to be associated with poor survival in advanced GBC patients. 26715268

2016

dbSNP: rs3834129
rs3834129
0.010 GeneticVariation BEFREE Carriers for the "del" allele of rs3834129 SNP were associated with a 0.60-fold decreased risk for GBC (95% CI = 0.42-0.88; P(trend) = 0.005). 20564345

2010

dbSNP: rs11887534
rs11887534
0.020 GeneticVariation BEFREE Carriers of the CG genotype of ABCG8 rs11887534 had higher risk of biliary stones [odds ratio (OR) = 2.3, 95% confidence interval (CI) 0.82-6.5), gallbladder cancer (OR = 4.3, 95% CI 1.7-10.4) and bile duct cancer (OR = 1.94, 95% CI 0.64-5.91), compared with carriers of the GG genotype. 21062971

2011

dbSNP: rs743572
rs743572
0.010 GeneticVariation BEFREE CYP17 rs743572 is associated with increased risk of GBC in tobacco users in the North Indian population. 24687554

2014

dbSNP: rs11954856
rs11954856
APC
0.010 GeneticVariation BEFREE Gene-gene interaction using GMDR analysis predicted APC rs11954856 and AXIN2 rs4791171 as significant in conferring GBC susceptibility. 26715268

2016

dbSNP: rs2486758
rs2486758
0.010 GeneticVariation BEFREE Hence, the present study aimed to investigate the association of CYP17 (rs2486758, and rs743572) polymorphisms with GBC susceptibility. 24687554

2014

dbSNP: rs2234767
rs2234767
0.010 GeneticVariation BEFREE Hence, the present study aimed to investigate the association of functional SNPs of DR4 (rs20575, rs20576 and rs6557634), FAS (rs2234767) and FASL (rs763110) with gallbladder cancer (GBC) risk. 24587306

2014

dbSNP: rs763110
rs763110
0.010 GeneticVariation BEFREE Hence, the present study aimed to investigate the association of functional SNPs of DR4 (rs20575, rs20576 and rs6557634), FAS (rs2234767) and FASL (rs763110) with gallbladder cancer (GBC) risk. 24587306

2014

dbSNP: rs25487
rs25487
0.010 GeneticVariation BEFREE However, Arg399Gln polymorphism and Arg-Gln haplotype comprising XRCC1 Arg194Trp and Arg399Gln polymorphisms conferred low risk for GBC susceptibility. 19266243

2009

dbSNP: rs1799782
rs1799782
0.010 GeneticVariation BEFREE However, Arg399Gln polymorphism and Arg-Gln haplotype comprising XRCC1 Arg194Trp and Arg399Gln polymorphisms conferred low risk for GBC susceptibility. 19266243

2009

dbSNP: rs746702110
rs746702110
0.010 GeneticVariation BEFREE However, Arg399Gln polymorphism and Arg-Gln haplotype comprising XRCC1 Arg194Trp and Arg399Gln polymorphisms conferred low risk for GBC susceptibility. 19266243

2009

dbSNP: rs909629195
rs909629195
0.010 GeneticVariation BEFREE In conclusion, LASP-1 may act as an oncogene to regulate the expression of S100P to influence cellular functions in GBC. 26797416

2016

dbSNP: rs1157
rs1157
0.010 GeneticVariation BEFREE In GMDR analysis, ALCAM rs1157G>A, EpCAM rs1126497T>C emerged as best significant interaction model with GBC susceptibility and ALDH1A1 rs13959T>G with increased risk of grade 3-4 hematological toxicity. 26318430

2016

dbSNP: rs1126497
rs1126497
0.010 GeneticVariation BEFREE In GMDR analysis, ALCAM rs1157G>A, EpCAM rs1126497T>C emerged as best significant interaction model with GBC susceptibility and ALDH1A1 rs13959T>G with increased risk of grade 3-4 hematological toxicity. 26318430

2016

dbSNP: rs13959
rs13959
0.010 GeneticVariation BEFREE In GMDR analysis, ALCAM rs1157G>A, EpCAM rs1126497T>C emerged as best significant interaction model with GBC susceptibility and ALDH1A1 rs13959T>G with increased risk of grade 3-4 hematological toxicity. 26318430

2016

dbSNP: rs2228001
rs2228001
XPC
0.010 GeneticVariation BEFREE In this study, we detected two non-synonymous polymorphisms in XPC (Ala499Val and Lys939Gln) in 334 cases of GBC and 329 subjects of hospital-based age- and sex frequency-matched controls in China using a polymerase chain reaction-restriction fragment length polymorphism assay. 21113018

2011

dbSNP: rs35463555
rs35463555
0.010 GeneticVariation BEFREE LXR-β genotypes (rs35463555) [GA + AA] and (rs2695121) [TC + CC] were associated with risk of GBC [OR = 1.46, p = 0.03; OR = 1.52, p = 0.01, respectively] as compared to healthy controls whereas LXR-α (rs7120118) was not associated with GBC risk. 23838803

2013

dbSNP: rs2695121
rs2695121
0.020 GeneticVariation BEFREE LXR-β genotypes (rs35463555) [GA + AA] and (rs2695121) [TC + CC] were associated with risk of GBC [OR = 1.46, p = 0.03; OR = 1.52, p = 0.01, respectively] as compared to healthy controls whereas LXR-α (rs7120118) was not associated with GBC risk. 23838803

2013

dbSNP: rs7120118
rs7120118
0.010 GeneticVariation BEFREE LXR-β genotypes (rs35463555) [GA + AA] and (rs2695121) [TC + CC] were associated with risk of GBC [OR = 1.46, p = 0.03; OR = 1.52, p = 0.01, respectively] as compared to healthy controls whereas LXR-α (rs7120118) was not associated with GBC risk. 23838803

2013

dbSNP: rs104886003
rs104886003
0.010 GeneticVariation BEFREE Mutations in exons 9 (E542K, E545G, E545K) and 20 (H1047L and H1047R) of PI3K were determined by direct sequencing in 130 cases of GBC. 26947513

2016

dbSNP: rs752742313
rs752742313
0.010 GeneticVariation BEFREE Mutations in exons 9 (E542K, E545G, E545K) and 20 (H1047L and H1047R) of PI3K were determined by direct sequencing in 130 cases of GBC. 26947513

2016